Javier Robles-Valero

6PUBLICATIONS
28CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2022
Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model.

Javier Robles-Valero, Lucía Fernández-Nevado, Myriam Cuadrado

|Oct 07, 2021
Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.

Javier Robles-Valero, Lucía Fernández-Nevado, L Francisco Lorenzo-Martín

|Sep 28, 2021
VAV Proteins as Double Agents in Cancer: Oncogenes with Tumor Suppressor Roles.

Myriam Cuadrado, Javier Robles-Valero

|Jun 13, 2020
Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor.

L Francisco Lorenzo-Martín, Sonia Rodríguez-Fdez, Salvatore Fabbiano

|Jan 10, 2018
Rho guanosine nucleotide exchange factors are not such bad guys after all in cancera.

Javier Robles-Valero, L Francisco Lorenzo-Martín, Isabel Fernández-Pisonero

Pageof 1